Transcriptome Profiling of Human Follicle Dermal Papilla Cells in response to Porphyra-334 Treatment by RNA-Seq

Figure 3

Clinical tests of porphyra-334 for improving periorbital wrinkles. Test (containing porphyra-334 (10 ppm)) and control (without porphyra-334) products were used. Six periorbital wrinkling parameters ((a) R3, average roughness; (b) R1, skin roughness; (c) R2, maximum roughness; (d) R4, smoothness depth; (e) R5, arithmetic average roughness, and (f) visual assessment) were measured for 22 participants at three different time points: baseline, 6 weeks (6 (W), and 12 weeks (12 (W). For the comparisons with baseline, we conducted paired samples t-tests. ^∗ indicates . For the comparisons between the test group and the control group, we used independent t-tests. ^# indicates . For the visual assessment, we used the Wilcoxon signed ranks test and Mann–Whitney U test. ^†. ^‡. AU = arbitrary unit.

(a)

(b)

(c)

(d)

(e)

(f)